Concomitant use of valproic acid (VPA) and meropenem (MEPM) is associated with a decrease in VPA plasma levels, according to a study published online in the Journal of Clinical Pharmacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback